[1P-0613] Development of a novel peptide-based therapeutic agent against CML by targeting PH domain of p210 BCR-ABL.
chronic myeloid leukemia, PH domain, cardiolipin, mitophagy, peptide-based agent
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.